This inventor holds 1 USPTO granted patent. Top assignee: Dsm IP Assets B.v.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jeroen Godefrooij: Innovator in Maltogenic Alpha-Amylase
Introduction
Jeroen Godefrooij is a notable inventor based in Echt, Netherlands. He has made significant contributions to the field of biotechnology, particularly in enzyme technology. His work focuses on the development of innovative polypeptides that enhance various industrial processes.
Latest Patents
Godefrooij holds a patent for a variant maltogenic alpha-amylase. This invention relates to a polypeptide that exhibits maltogenic alpha-amylase activity. The polypeptide comprises specific amino acid substitutions, including F188L/I, S200N, and D261G, with an optional further substitution of T288P. The polypeptide's amino acid sequence shows a high degree of identity to a reference sequence, making it a valuable asset in the production of dough and baked products.
Career Highlights
Jeroen Godefrooij is associated with DSM IP Assets B.V., a company known for its focus on innovation in health and nutrition. His work at DSM has allowed him to explore the practical applications of his inventions in the food industry. Godefrooij's expertise in enzyme technology has positioned him as a key player in the development of new products that improve food quality and processing efficiency.
Collaborations
Godefrooij has collaborated with notable colleagues, including Helma Arina Stolze-Lagerweij and René Marcel De Jong. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of innovative solutions in enzyme technology.
Conclusion
Jeroen Godefrooij's contributions to the field of maltogenic alpha-amylase represent a significant advancement in biotechnology. His innovative approach and collaboration with industry experts continue to drive progress in enzyme applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
